A pharmaceutical composition comprising a pharmaceutically acceptable salt of [2-(3-fluoro-5-methanesulfonylphenoxy)ethyl](propyl)amine, and a pharmaceutical drug for Parkinson's disease, and uses of said pharmaceutical composition
The invention provides a compound of Formula I, or a pharmaceutically acceptable salt thereof, for use in the prevention or reduction of sensitization to a pharmaceutical drug for Parkinson's disease. The invention further provides a compound of Formula I or a pharmaceutically acceptable salt t...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SVENNINGSSON, PER TEDROFF, JOAKIM MIHKEL HOLM WATERS, SUSANNA |
| description | The invention provides a compound of Formula I, or a pharmaceutically acceptable salt thereof, for use in the prevention or reduction of sensitization to a pharmaceutical drug for Parkinson's disease. The invention further provides a compound of Formula I or a pharmaceutically acceptable salt thereof, for use in optimization of the dosage of a pharmaceutical drug for Parkinson's disease (e.g. L-DOPA or a pharmaceutically acceptable salt thereof). |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_TW202233169A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>TW202233169A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_TW202233169A3</originalsourceid><addsrcrecordid>eNqNj7FKBEEQRDcxEPUf2sg7cEB3UTA8RDE0ODAQOdrZntvB3u5hegacL_Y3POUiBTGqonhFUYfdxwrShHlGT7VEjwxe56QWS1T59jlalC3gD44boPeUCr4ygSEX0ADPvVsMLnDVrO7KzVQmFLLKQaVxmkj0vS13aeOXRcqaGi9xjkLngDL-GoEx1y0EzfCI-S2KqZwZjNEIbV-pRva1bBjHP64cdwcB2ehkr0fd6f3d-vbBUdINWdqVhMpm_dRf9P0wXF7frIb_MJ9vX3B2</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>A pharmaceutical composition comprising a pharmaceutically acceptable salt of [2-(3-fluoro-5-methanesulfonylphenoxy)ethyl](propyl)amine, and a pharmaceutical drug for Parkinson's disease, and uses of said pharmaceutical composition</title><source>esp@cenet</source><creator>SVENNINGSSON, PER ; TEDROFF, JOAKIM MIHKEL ; HOLM WATERS, SUSANNA</creator><creatorcontrib>SVENNINGSSON, PER ; TEDROFF, JOAKIM MIHKEL ; HOLM WATERS, SUSANNA</creatorcontrib><description>The invention provides a compound of Formula I, or a pharmaceutically acceptable salt thereof, for use in the prevention or reduction of sensitization to a pharmaceutical drug for Parkinson's disease. The invention further provides a compound of Formula I or a pharmaceutically acceptable salt thereof, for use in optimization of the dosage of a pharmaceutical drug for Parkinson's disease (e.g. L-DOPA or a pharmaceutically acceptable salt thereof).</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220901&DB=EPODOC&CC=TW&NR=202233169A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220901&DB=EPODOC&CC=TW&NR=202233169A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SVENNINGSSON, PER</creatorcontrib><creatorcontrib>TEDROFF, JOAKIM MIHKEL</creatorcontrib><creatorcontrib>HOLM WATERS, SUSANNA</creatorcontrib><title>A pharmaceutical composition comprising a pharmaceutically acceptable salt of [2-(3-fluoro-5-methanesulfonylphenoxy)ethyl](propyl)amine, and a pharmaceutical drug for Parkinson's disease, and uses of said pharmaceutical composition</title><description>The invention provides a compound of Formula I, or a pharmaceutically acceptable salt thereof, for use in the prevention or reduction of sensitization to a pharmaceutical drug for Parkinson's disease. The invention further provides a compound of Formula I or a pharmaceutically acceptable salt thereof, for use in optimization of the dosage of a pharmaceutical drug for Parkinson's disease (e.g. L-DOPA or a pharmaceutically acceptable salt thereof).</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNj7FKBEEQRDcxEPUf2sg7cEB3UTA8RDE0ODAQOdrZntvB3u5hegacL_Y3POUiBTGqonhFUYfdxwrShHlGT7VEjwxe56QWS1T59jlalC3gD44boPeUCr4ygSEX0ADPvVsMLnDVrO7KzVQmFLLKQaVxmkj0vS13aeOXRcqaGi9xjkLngDL-GoEx1y0EzfCI-S2KqZwZjNEIbV-pRva1bBjHP64cdwcB2ehkr0fd6f3d-vbBUdINWdqVhMpm_dRf9P0wXF7frIb_MJ9vX3B2</recordid><startdate>20220901</startdate><enddate>20220901</enddate><creator>SVENNINGSSON, PER</creator><creator>TEDROFF, JOAKIM MIHKEL</creator><creator>HOLM WATERS, SUSANNA</creator><scope>EVB</scope></search><sort><creationdate>20220901</creationdate><title>A pharmaceutical composition comprising a pharmaceutically acceptable salt of [2-(3-fluoro-5-methanesulfonylphenoxy)ethyl](propyl)amine, and a pharmaceutical drug for Parkinson's disease, and uses of said pharmaceutical composition</title><author>SVENNINGSSON, PER ; TEDROFF, JOAKIM MIHKEL ; HOLM WATERS, SUSANNA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_TW202233169A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SVENNINGSSON, PER</creatorcontrib><creatorcontrib>TEDROFF, JOAKIM MIHKEL</creatorcontrib><creatorcontrib>HOLM WATERS, SUSANNA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SVENNINGSSON, PER</au><au>TEDROFF, JOAKIM MIHKEL</au><au>HOLM WATERS, SUSANNA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>A pharmaceutical composition comprising a pharmaceutically acceptable salt of [2-(3-fluoro-5-methanesulfonylphenoxy)ethyl](propyl)amine, and a pharmaceutical drug for Parkinson's disease, and uses of said pharmaceutical composition</title><date>2022-09-01</date><risdate>2022</risdate><abstract>The invention provides a compound of Formula I, or a pharmaceutically acceptable salt thereof, for use in the prevention or reduction of sensitization to a pharmaceutical drug for Parkinson's disease. The invention further provides a compound of Formula I or a pharmaceutically acceptable salt thereof, for use in optimization of the dosage of a pharmaceutical drug for Parkinson's disease (e.g. L-DOPA or a pharmaceutically acceptable salt thereof).</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_TW202233169A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | A pharmaceutical composition comprising a pharmaceutically acceptable salt of [2-(3-fluoro-5-methanesulfonylphenoxy)ethyl](propyl)amine, and a pharmaceutical drug for Parkinson's disease, and uses of said pharmaceutical composition |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T06%3A15%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SVENNINGSSON,%20PER&rft.date=2022-09-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ETW202233169A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |